 China Meheco Corporation is a state-holding listed company at Shanghai stock exchanges (stock name "China Medicine", code:600056),with China General Technology (Group) Holding Co., Ltd as it's shareholder. With a commitment of "cherishing life, seeking excellence", it is dedicated to the development of the medical industry and human health，and strive to be a flagship enterprise of Chinese medicine industry in recent future.
The main business scope of the corporation covers five core business fields, which are botanical medicines, medical & chemical industry, medical instruments, pharmaceutical business and comprehensive trade, and involves several business operating formats such as international trade, domestic trade, production, scientific research and development, logistics and technology service etc.. The corporation has now cultivated a primary pattern of industrialized operation integrating trade, production and scientific research.
In the field of botanical medicines, the corporation owns an international leading product quality tracing back management system and a domestic first-class herbal pieces production and processing platform. In the field of medical & chemical industry, it has built up a modern production platform of a special chemical preparation, anti-infection medicine. At the same time, the corporation has a good partnership with many famous foreign medicine companies, which gives the corporation a strong competitive advantage in the medicines of prevention and treatment to the infectious diseases, diagnostic products and biological products. In the field of medical instrument，the corporation is one of the biggest logistic distributors of import medical instrument. Relying on the warehouse logistic platform and general bonded warehouses, and depending on specialized manner of input and distribution and the ability of technology service, it keeps a sustainable and stabilized partnership with the major medical instrument manufacturers in the world. In the field of pharmaceutical business, the corporation has established nationwide pharmaceutical business network and distribution channels which cover all important medication cities in the country. By integrating with the advantage resources in the international market, the corporation has been establishing an integrated pharmaceutical business network both home and abroad. In the field of comprehensive trade, the corporation owns specialized International trade professionals and nationwide network resources, has a unique competitive advantage in the bulk commodities and special market trade.
In the future, China Meheco Corporation will comply with the guiding spirit ”expanding trade, strengthening marketing and starting industrial”, focus on building trading network systems both in foreign market and domestic market by strategic transition investment and traditional business transition and upgrade. According to cultivating a mode of industrialized operation integrating research & development, production, trade and service in the core industrialized fields, the corporation will put every effort to make it to be a large-scale pharmaceutical enterprise group integrating scientific research, trade and production, which then is a big role in domestic medicine market and has a strong competition and brand influence in the international market. |
Product Categories